Advertisement

Topics

Latest "Z.Inc" News Stories

16:59 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Z.Inc" found in our extensive news archives from over 250 global news sources.

More Information about Z.Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Z.Inc for you to read. Along with our medical data and news we also list Z.Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Z.Inc Companies for you to search.

Showing News Articles 1–25 of 430,000+

Monday 22nd October 2018

$PETX exploring strategic alternatives; according to Dealreporter +8.7%

$PETX exploring strategic alternatives; according to Dealreporter +8.7%


Senseonics Announces Aetna’s Positive Coverage Decision for Eversense

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that Aetna, the third largest commercial health plan provider in the United States, is providing coverage for Eversens...

[Articles] Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a

Each dosing regimen of ixekizumab was superior to placebo for improving radiographic axial spondyloarthritis signs and symptoms in patients not previously treated with bDMARDs; the safety profile was consistent with previous indications of ixekizumab.


[Comment] Learning from the youngsters: ixekizumab in active ankylosing spondylitis

The COAST-V study published by Désirée van der Heijde and colleagues in The Lancet1 shows that ixekizumab, a monoclonal antibody that selectively targets interleukin (IL)-17A, is efficacious in patients with ankylosing spondylitis (also known as radiographic axial spondyloarthritis) who have previously been untreated with biological disease-modifying antirheumatic drugs (bDMARDs). Ixekizumab has...

Global Dried Cashew Nut Snack Market Status and Outlook 20182025 [Report Updated: 19082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 2018, after the market closes on Monday, November 5, 2018. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, November 6, 2018 at 8:30 AM ET. ...

HealthStream Announces Third Quarter 2018 Results

HealthStream, Inc. (NASDAQ: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, announced today results for the third quarter ended September 30, 2018. In the following bullet-point highlights, (i) all results are from continuing operations only (i.e., 2017 and 2018 results exclude the gain on the sale of our divested...

Quanterix Announces Collaboration with OncoGenesis to Develop Cervical Screening Test

Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration agreement with OncoGenesis, a molecular protein-based cervical screening

Celgene Corporation Announces Appointment of Dr. Alise Reicin to President, Global Clinical Development

Dr. Alise Reicin will lead mid- to late-stage drug development across Celgene’s portfolio New organizational structure enhances corporate strategy and focus on discovery, development and commercialization Celgene Corporation (NASDAQ:CELG) today announced the appointment of Dr. Alise Reicin to President, Global Clinical Development, reporting...

ResMed Wins German Patent Infringement Case Against Fisher & Paykel

Court finds headgear used on Simplus and Eson 2 CPAP masks infringes ResMed patent ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea and respiratory care, today announced the results of a court and patent office ruling in Germany in ResMed’s favor. A trial court ruling from t...

Heidelberg Pharma AG WL6 Financial and Strategic SWOT Analysis Review [Report Updated: 25072018] Prices from USD $125

Heidelberg Pharma AG WL6 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment y...

Livzon Pharmaceutical Group Inc 000513 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryLivzon Pharmaceutical Group Inc Livzon, a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and intermediates, and diagnostic reagents and equipment. Its products include menotropins injection, urofollit...

Global Ultrasonic Thickness Gauges Market Status and Outlook 20182025 [Report Updated: 12082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

GlyTR Therapeutics ‘Cancer Moonshot’ Technology Receives Second Grant from the National Cancer Institute

GlyTR Therapeutics, Inc. is pleased to announce it has been awarded an approximately $300,000 grant from The National Cancer Institute (NCI), National Institute of Health (NIH) thru the Small Business Technology Transfer Program. This grant award comes on the heels of a $3.4 million grant on its Glycan dependent T

Innovation Could Lead to ‘Green’ Flexible Electronic Composite Material

ArticleA team from the University of Massachusetts Amherst has developed a new class of electronic materials that could yield more green and sustainable technology in biomedical and environmental sensing.

e.l.f. Beauty Announces Third Quarter 2018 Earnings Release Date and Conference Call and Webcast

e.l.f. Beauty (NYSE: ELF) today announced that the Company will conduct a conference call to discuss its third quarter fiscal 2018 results on Monday, November 5, 2018, at 4:30 p.m. Eastern Time. A press release detailing the Company’s third quarter fiscal 2018 results will be issued prior to the call. The conference call will be hosted by Tarang Amin, Ch...

Endologix, Inc. to Announce Third Quarter 2018 Financial Results on November 1, 2018

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the ...

AtriCure to Participate in Upcoming Investor Conferences

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will be participating in upco

Castle Dental Opens a New Houston Location at the Shops at Three Corners

Join the office for its Grand Opening even on Tuesday October 23rd IRVINE, Calif. (PRWEB) October 22, 2018 Smile Brands Inc., one of the nation’s leading providers of business support services to dental groups in the United States, is announcing today’s opening of its newest Castle Dental office. After nearly 25 years at the at 8455 Fannin Street location in Houston, Castle Dental has moved t...

Global Automotive Chassis Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Zogenix Inc ZGNX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryZogenix Inc Zogenix is a provider of therapies for central nervous system disorders. The company's product portfolio comprises Zohydro ER, Sumavel DosePro and undisclosed dosepro CNS product candidate. Its pipeline products include Relday and ZX008. Zogenix's Sumavel DosePro is a prefilled needlefree delivery system that treats people with acute migraine or cluster headaches. The company de...

Pompe Disease Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Pompe Disease Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease Pipeline Review, H2 2018, provides an overview of the Pompe Disease Metabolic Disorders pipeline landscape.Pompe disease is an inherited disorder caused by defect in a gene called GAA. The GAA gene is responsible for the production of the GAA enzyme acid ...

Nitrogen Supply Depleting as Temperatures Rise

ArticleThe availability of nitrogen for trees and other plants is declining, likely due to climate change. Staff Author: 

Seoul National University Hospital Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummarySeoul National University Hospital SNUH is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation's healthcare system, medical education, research and patient care. It offers services such as outpatient, inpatient, medical examination, billing and insurance, issuance service, emergency service and hom...

Mystery of How Black Widow Spiders Create Steel-Strength Silk Webs Further Unravelled

News'Modified micelle theory' may allow scientists to create equally strong synthetic materials. Contributed Author: 


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks